OmniMD EHRLite vs LabelRx

OmniMD EHRLite is the Smartphone extension of OmniMD Certified EHR with necessary functionalities. Physicians can access the patient information and perform certain important functions from the mobile device, such as Search, View, Add, Edit Patient Medical Records, Dictations, ePrescriptions, Laboratory, Charge Capture, etc. However, in this version only Dictations (Transcriptions) module is available. To use this app, a User should have an existing active account with OmniMD.

LabelRx is a clinical drug reference for licensed healthcare professionals — pharmacists, physicians, advanced-practice nurses, residents, and pharmacy/medical students. Free, no ads, no account required. Every FDA prescription drug, every label, every Boxed Warning — searchable in seconds and sourced straight from the authoritative public registries the FDA publishes. — Data sources — • DailyMed (NIH / National Library of Medicine) — the full FDA-approved Structured Product Labeling (SPL) for every U.S. prescription drug • Drugs@FDA — approval history, NDA / ANDA / BLA numbers, sponsors, application letters • FDA Orange Book — therapeutic-equivalence (AB) codes for legal generic substitution, plus active patents and exclusivities • FDA Drug Shortages database — current shortages with reason, discontinuation, and resolution dates • FDA MedWatch — Class I / II / III recalls, enforcement reports, and safety alerts • ClinicalTrials.gov — every registered clinical trial on the approved drug • openFDA FAERS — aggregated post-market adverse event signal by MedDRA term • RxNorm — normalization across brand, generic, and ingredient names • CPIC — Clinical Pharmacogenetics Implementation Consortium gene-drug guidelines — What you get on every drug — • Boxed Warnings front and center, never buried • Dosing organized by indication, with renal and hepatic adjustments surfaced • Contraindications, warnings, and adverse reactions in clinical reading order • Pregnancy and lactation rendered per the FDA PLLR • Orange Book AB codes and therapeutic equivalents for generic substitution • Active patents and exclusivities so you see when generics are likely • Active FDA recalls flagged at the top of the drug • REMS programs surfaced as advisories • Controlled-substance schedule (CI–CV) badge • Pharmacokinetics: half-life, protein binding, dialyzability, CYP substrate / inhibitor / inducer • Pharmacogenomics: CPIC Level A gene-drug guidelines (CYP2C19, CYP2D6, TPMT, UGT1A1, HLA-B, DPYD, SLCO1B1, and more) • Post-market FAERS adverse event signal aggregated by MedDRA term • Clinical trial activity from ClinicalTrials.gov — Clinical calculators — 90+ calculators across nephrology, hepatology, cardiology, ID, psychiatry, oncology, hematology, obstetrics, geriatrics, critical care, and general medicine. Every formula cites primary sources (KDIGO, CKD-EPI 2021, Cockcroft-Gault, MELD 3.0, CHA₂DS₂-VASc, HAS-BLED, Wells, PERC, GRACE, TIMI, Alvarado, Glasgow-Blatchford, Child-Pugh, APACHE II, SOFA, qSOFA, CIWA-Ar, COWS, PHQ-9, GAD-7, AUDIT, EPDS, Bishop, Parkland, ASCVD, Beers Criteria, Schwartz pediatric GFR, Holliday-Segar fluids, Vancomycin AUC/MIC, Opioid MME per CDC 2022, and many more). Every calculator shows its formula, citation, and a clinical-use disclaimer. — Tools — • Renal Dose Adjustment lookup against the actual FDA label text • Substitution Finder using real Orange Book TE codes • Pregnancy & Lactation reference • Drug Shortage tracker (live FDA feed) • Label Co-Mentions (label-text search, NOT a validated DDI database) — News & alerts — • FDA new approvals feed, straight from Drugs@FDA • Push notifications for label changes and shortages on drugs you save • Daily clinical assessment to keep your knowledge sharp — Disclaimer — LabelRx is a reference. It is not FDA-cleared as a medical device or as clinical decision support software. Always verify with the current FDA-approved prescribing information, your institutional protocols, and your own clinical judgment. Not a substitute for the full prescribing information or a licensed clinician.